BioCentury
ARTICLE | Clinical News

Diamyd: Phase II start

February 4, 2013 8:00 AM UTC

This month, Diamyd said that Linkoping University will begin the 30-month, double-blind, Swedish Phase II DIABGAD-1 trial to evaluate Diamyd in 60 Type I diabetics ages 10-18 years. Patients will rece...